May 8, 2013
ACO and Exchange Information is the Most Critical to Understand in the next Six Months, According to Decision Resources Group
March 5, 2013
Healthcare consolidations are on the rise, as industry stakeholders anticipate the Jan. 1, 2014, launch of several healthcare reform initiatives. With the increase in mergers and acquisitions activity has come more stringent and effective antitrust review from the Federal Trade Commission.
December 20, 2012
Clinical Pathways May Factor into ACO Reimbursement Strategies
The adoption of clinical pathways in oncology has the potential to streamline care. Breast cancer, colorectal cancer, and non-small-cell lung cancer appear to be the conditions that are the current priorities for pathway programs, according to a new report from Decision Resources entitled, “Impact of Payer-Imposed Strategies on Market Access in Oncology: Clinical Pathways, Accountable Care Organization Contracting, Specialty Pharmacy, and the Evolution of the Buy and Bill Model.”